论文部分内容阅读
目的探讨雷贝拉唑联合胃力胶囊治疗胃食管反流病(GERD)的疗效。方法治疗组31例,采用雷贝拉唑+胃力胶囊治疗,4周为一个疗程。对照组30例,单用雷贝拉唑治疗,4周为一个疗程。结果治疗一个疗程后,治疗组与对照组相比较,症状缓解率,食管黏膜糜烂的愈合率,治疗组明显优于对照组,差异有统计学意义(P<0.05)。结论雷贝拉唑联合胃力胶囊治疗GERD可获得满意的临床疗效。
Objective To investigate the curative effect of rabeprazole combined with Weili Capsule in the treatment of gastroesophageal reflux disease (GERD). Methods 31 cases of treatment group, the use of rabeprazole + Wei Li capsule treatment, 4 weeks for a course of treatment. The control group of 30 patients treated with rabeprazole alone, 4 weeks for a course of treatment. Results After treatment for one course of treatment, the healing rate of esophageal mucosal erosion in the treatment group was significantly higher than that in the control group (P <0.05). Conclusion Rabeprazole combined with Wei-Li Capsule in the treatment of GERD can achieve satisfactory clinical efficacy.